Header Logo

Connection

AHMED ELKHANANY to Everolimus

Back to Details
This is a "connection" page, showing publications AHMED ELKHANANY has written about Everolimus.
AHMED ELKHANANY
Connection Strength
0.047
Everolimus
  1. A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. Breast Cancer Res Treat. 2023 Apr; 198(2):217-229.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.